Allogene Therapeutics, Inc. - ALLO

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 29
Latest filed: Sep 02, 2026
Form Count
4 11
8-K 8
SCHEDULE 13G/A 6
144 3
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
Sep 02, 2026 8-K Aug 31, 2026 0001193125-26-379423 View
Aug 25, 2026 4 Aug 21, 2026 0001628280-26-058920 View
Aug 21, 2026 144 0001737287-26-000023 View
Aug 14, 2026 SCHEDULE 13G/A 0001231919-26-000912 View
Aug 12, 2026 8-K Aug 12, 2026 0001628280-26-056198 View
Aug 07, 2026 SCHEDULE 13G/A 0001296549-26-000008 View
Jul 06, 2026 4 Jul 01, 2026 0001851044-26-000005 View
Jun 23, 2026 4 Jun 18, 2026 0001221355-26-000002 View
Jun 23, 2026 4 Jun 18, 2026 0001764157-26-000004 View
Jun 23, 2026 4 Jun 18, 2026 0001548072-26-000002 View
Jun 23, 2026 4 Jun 18, 2026 0001700969-26-000002 View
Jun 23, 2026 4 Jun 18, 2026 0001197020-26-000002 View
Jun 23, 2026 4 Jun 18, 2026 0001737287-26-000019 View
Jun 23, 2026 4 Jun 18, 2026 0001737287-26-000021 View
Jun 22, 2026 8-K Jun 18, 2026 0001628280-26-044618 View
May 28, 2026 8-K May 28, 2026 0001193125-26-245484 View
May 15, 2026 SCHEDULE 13G/A 0000902664-26-002534 View
May 15, 2026 SCHEDULE 13G/A 0001104659-26-062730 View
May 13, 2026 SCHEDULE 13G/A 0001296549-26-000006 View
May 13, 2026 SCHEDULE 13G/A 0001611024-26-000005 View
May 13, 2026 8-K May 12, 2026 0001628280-26-034583 View
Apr 23, 2026 SCHEDULE 13G 0001231919-26-000398 View
Apr 23, 2026 4 Apr 21, 2026 0001835208-26-000003 View
Apr 21, 2026 144 0001835208-26-000001 View
Apr 15, 2026 8-K Apr 14, 2026 0001193125-26-157140 View
Apr 13, 2026 8-K Apr 13, 2026 0001193125-26-152866 View
Apr 13, 2026 8-K Apr 13, 2026 0001193125-26-151999 View
Apr 02, 2026 4 Mar 31, 2026 0002057918-26-000007 View
Apr 01, 2026 144 0002057918-26-000005 View